Join the 'Lupaneta Pack' group to help and get support from people like you.
Lupaneta Pack News
Posted 30 Sep 2015 by Drugs.com
WEDNESDAY, Sept. 30, 2015 – Women who start hormone therapy toward the beginning of menopause may have a lower risk of developing heart disease, new research suggests. The study, of over 74,000 Swedish women, found that those who started hormone therapy within five years of beginning menopause typically stayed free of heart disease for a longer time than non-users. In contrast, women who started hormone therapy later showed an increase in their heart disease risk. "This is in line with what a number of studies have shown," said Dr. Sonia Tolani, of the Women's Center for Cardiovascular Health at New York-Presbyterian Hospital, in New York City. "There does seem to be a relationship between the timing of hormone therapy and heart disease risk," said Tolani, who was not involved in the study. However, she stressed, that doesn't mean women should routinely use hormones when menopause ... Read more
Related support groups: Plan B, Mirena, Provera, Nexplanon, Implanon, Depo-Provera, Microgestin Fe 1/20, Hot Flashes, Loestrin 24 Fe, Plan B One-Step, Estradiol, Menopausal Disorders, Lo Loestrin Fe, Premarin, Medroxyprogesterone, Levonorgestrel, Ethinyl Estradiol, Estrace, Progesterone, Junel Fe 1/20